BEIJING SUCCEEDER TECHNOLOGY (688338.SS)

Saturday

10:27 AM

Thesis: The company's declining revenue growth and net income suggest underlying challenges that may affect investor confidence.

Revenue Outlook

Metric	FY2025	FY2026E	FY2027E
Revenue	$264M	$424M	$502M
Rev. Growth	-13.8%	+60.8%	+18.4%
EPS	$0.85	$1.39	$1.59
EPS Growth	-20.6%	+63.5%	+14.4%
P/E (fwd)	36.3×	22.2×	19.4×

★ Analysts see FY2026 revenue reaching $424M — +60.8% growth in a single year.

What Moves the Stock

1Regulatory approvals for new medical devices
2Market penetration in tier-1 and tier-2 cities in China
3Partnerships with healthcare institutions for product adoption
4Technological advancements in medical device manufacturing
5Diagnostic imaging devices (approximately 70%)
6Minimally invasive surgical tools (approximately 30%)
7Digital health integration
8Minimally invasive surgical techniques

FY2025 Snapshot

Revenue: $264M
Rev. Growth: -13.8%
Gross Margin: 100%
Op. Margin: 39.1%
Net Margin: 34.0%
Net Income: $90M
NI Growth: -20.7%
EPS: $0.85
1Y Return: +17.1%

688338.SS Chart

My Notes

"Management indicated a need to reassess product strategies to adapt to changing market conditions."
Moat: The company's competitive advantage is supported by a strong patent portfolio and established relationships with healthcare providers…
growth - Investors are likely attracted to the potential for rapid revenue growth in the healthcare sector, particularly in China.
Interest rates have minimal direct impact on the company as it operates with no debt.
Watch on earnings: Regulatory approval timelines for new products, Market share in diagnostic imaging devices, Sales growth in minimally invasive surgical tools.

One Sentence Summary:

Beijing Succeeder Technology: the story is balanced — regulatory approvals for new medical devices.

Auto-composed from Stock Alarm intelligence, financial statements, and analyst estimates. Not investment advice.

Writing up the research note…

First read for a new ticker takes about 20–30 seconds while we build the analysis from the latest fundamentals, estimates, and intelligence. It's saved after this, so future visits are instant.

Explore More

S&P 500 Screener

Filter and sort all 500 stocks

Market Movers

Today's biggest gainers and losers

Market Heatmap

Visual sector performance